Selected research
Market Outlook & Growth Opportunities
Global Glucoraphanin and Sulforaphane Market Outlook and Growth Opportunities 2026
Market perspective
The global Glucoraphanin and Sulforaphane market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Glucoraphanin and Sulforaphane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Glucoraphanin and Sulforaphane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Glucoraphanin and Sulforaphane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Glucoraphanin and Sulforaphane market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Glucoraphanin and Sulforaphane market include Brassica, CS Health, Ingood by Olga, ETChem, Pioneer Herb Industrial, Shanxi Yian and Anhui Bensentang Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Glucoraphanin and Sulforaphane market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glucoraphanin and Sulforaphane and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glucoraphanin and Sulforaphane sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucoraphanin and Sulforaphane market size, projected growth trends, production technologies, key applications, and end-use industries.
Glucoraphanin and Sulforaphane Segment by Company
Brassica
CS Health
Ingood by Olga
ETChem
Pioneer Herb Industrial
Shanxi Yian
Anhui Bensentang Biotechnology
Glucoraphanin and Sulforaphane Segment by Type
Glucoraphanin
Sulforaphane
Glucoraphanin and Sulforaphane Segment by Application
Health Products
Functional Foods
Pharmaceutical
Others
Glucoraphanin and Sulforaphane Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Glucoraphanin and Sulforaphane status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Glucoraphanin and Sulforaphane market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Glucoraphanin and Sulforaphane significant trends, drivers, influence factors in global and regions.
6. To analyze Glucoraphanin and Sulforaphane competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucoraphanin and Sulforaphane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucoraphanin and Sulforaphane and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucoraphanin and Sulforaphane.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glucoraphanin and Sulforaphane market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucoraphanin and Sulforaphane industry.
Chapter 3: Detailed analysis of Glucoraphanin and Sulforaphane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Glucoraphanin and Sulforaphane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Glucoraphanin and Sulforaphane in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Glucoraphanin
- Sulforaphane
Applications
- Health Products
- Functional Foods
- Pharmaceutical
- Others
Companies covered
- Brassica
- CS Health
- Ingood by Olga
- ETChem
- Pioneer Herb Industrial
- Shanxi Yian
- Anhui Bensentang Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Glucoraphanin and Sulforaphane Sales Value (2021-2032)
- 1.2.2 Global Glucoraphanin and Sulforaphane Sales Volume (2021-2032)
- 1.2.3 Global Glucoraphanin and Sulforaphane Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Glucoraphanin and Sulforaphane Market Dynamics
- 2.1 Glucoraphanin and Sulforaphane Industry Trends
- 2.2 Glucoraphanin and Sulforaphane Industry Drivers
- 2.3 Glucoraphanin and Sulforaphane Industry Opportunities and Challenges
- 2.4 Glucoraphanin and Sulforaphane Industry Restraints
3 Glucoraphanin and Sulforaphane Market by Company
- 3.1 Global Glucoraphanin and Sulforaphane Company Revenue Ranking in 2025
- 3.2 Global Glucoraphanin and Sulforaphane Revenue by Company (2021-2026)
- 3.3 Global Glucoraphanin and Sulforaphane Sales Volume by Company (2021-2026)
- 3.4 Global Glucoraphanin and Sulforaphane Average Price by Company (2021-2026)
- 3.5 Global Glucoraphanin and Sulforaphane Company Ranking (2024-2026)
- 3.6 Global Glucoraphanin and Sulforaphane Company Manufacturing Base and Headquarters
- 3.7 Global Glucoraphanin and Sulforaphane Company Product Type and Application
- 3.8 Global Glucoraphanin and Sulforaphane Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Glucoraphanin and Sulforaphane Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Glucoraphanin and Sulforaphane Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Glucoraphanin and Sulforaphane Market by Type
- 4.1 Glucoraphanin and Sulforaphane Type Introduction
- 4.1.1 Glucoraphanin
- 4.1.2 Sulforaphane
- 4.2 Global Glucoraphanin and Sulforaphane Sales Volume by Type
- 4.2.1 Global Glucoraphanin and Sulforaphane Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Glucoraphanin and Sulforaphane Sales Volume by Type (2021-2032)
- 4.2.3 Global Glucoraphanin and Sulforaphane Sales Volume Share by Type (2021-2032)
- 4.3 Global Glucoraphanin and Sulforaphane Sales Value by Type
- 4.3.1 Global Glucoraphanin and Sulforaphane Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Glucoraphanin and Sulforaphane Sales Value by Type (2021-2032)
- 4.3.3 Global Glucoraphanin and Sulforaphane Sales Value Share by Type (2021-2032)
5 Glucoraphanin and Sulforaphane Market by Application
- 5.1 Glucoraphanin and Sulforaphane Application Introduction
- 5.1.1 Health Products
- 5.1.2 Functional Foods
- 5.1.3 Pharmaceutical
- 5.1.4 Others
- 5.2 Global Glucoraphanin and Sulforaphane Sales Volume by Application
- 5.2.1 Global Glucoraphanin and Sulforaphane Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Glucoraphanin and Sulforaphane Sales Volume by Application (2021-2032)
- 5.2.3 Global Glucoraphanin and Sulforaphane Sales Volume Share by Application (2021-2032)
- 5.3 Global Glucoraphanin and Sulforaphane Sales Value by Application
- 5.3.1 Global Glucoraphanin and Sulforaphane Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Glucoraphanin and Sulforaphane Sales Value by Application (2021-2032)
- 5.3.3 Global Glucoraphanin and Sulforaphane Sales Value Share by Application (2021-2032)
6 Glucoraphanin and Sulforaphane Regional Sales and Value Analysis
- 6.1 Global Glucoraphanin and Sulforaphane Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Glucoraphanin and Sulforaphane Sales by Region (2021-2032)
- 6.2.1 Global Glucoraphanin and Sulforaphane Sales by Region: 2021-2026
- 6.2.2 Global Glucoraphanin and Sulforaphane Sales by Region (2027-2032)
- 6.3 Global Glucoraphanin and Sulforaphane Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Glucoraphanin and Sulforaphane Sales Value by Region (2021-2032)
- 6.4.1 Global Glucoraphanin and Sulforaphane Sales Value by Region: 2021-2026
- 6.4.2 Global Glucoraphanin and Sulforaphane Sales Value by Region (2027-2032)
- 6.5 Global Glucoraphanin and Sulforaphane Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Glucoraphanin and Sulforaphane Sales Value (2021-2032)
- 6.6.2 North America Glucoraphanin and Sulforaphane Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Glucoraphanin and Sulforaphane Sales Value (2021-2032)
- 6.7.2 Europe Glucoraphanin and Sulforaphane Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Glucoraphanin and Sulforaphane Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Glucoraphanin and Sulforaphane Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Glucoraphanin and Sulforaphane Sales Value (2021-2032)
- 6.9.2 South America Glucoraphanin and Sulforaphane Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Glucoraphanin and Sulforaphane Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Glucoraphanin and Sulforaphane Sales Value Share by Country, 2025 VS 2032
7 Glucoraphanin and Sulforaphane Country-level Sales and Value Analysis
- 7.1 Global Glucoraphanin and Sulforaphane Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Glucoraphanin and Sulforaphane Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Glucoraphanin and Sulforaphane Sales by Country (2021-2032)
- 7.3.1 Global Glucoraphanin and Sulforaphane Sales by Country (2021-2026)
- 7.3.2 Global Glucoraphanin and Sulforaphane Sales by Country (2027-2032)
- 7.4 Global Glucoraphanin and Sulforaphane Sales Value by Country (2021-2032)
- 7.4.1 Global Glucoraphanin and Sulforaphane Sales Value by Country (2021-2026)
- 7.4.2 Global Glucoraphanin and Sulforaphane Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.9.2 France Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.16.2 China Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.19.2 India Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Glucoraphanin and Sulforaphane Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Glucoraphanin and Sulforaphane Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Glucoraphanin and Sulforaphane Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Brassica
- 8.1.1 Brassica Company Information
- 8.1.2 Brassica Business Overview
- 8.1.3 Brassica Glucoraphanin and Sulforaphane Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Brassica Glucoraphanin and Sulforaphane Product Portfolio
- 8.1.5 Brassica Recent Developments
- 8.2 CS Health
- 8.2.1 CS Health Company Information
- 8.2.2 CS Health Business Overview
- 8.2.3 CS Health Glucoraphanin and Sulforaphane Sales, Value and Gross Margin (2021-2026)
- 8.2.4 CS Health Glucoraphanin and Sulforaphane Product Portfolio
- 8.2.5 CS Health Recent Developments
- 8.3 Ingood by Olga
- 8.3.1 Ingood by Olga Company Information
- 8.3.2 Ingood by Olga Business Overview
- 8.3.3 Ingood by Olga Glucoraphanin and Sulforaphane Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Ingood by Olga Glucoraphanin and Sulforaphane Product Portfolio
- 8.3.5 Ingood by Olga Recent Developments
- 8.4 ETChem
- 8.4.1 ETChem Company Information
- 8.4.2 ETChem Business Overview
- 8.4.3 ETChem Glucoraphanin and Sulforaphane Sales, Value and Gross Margin (2021-2026)
- 8.4.4 ETChem Glucoraphanin and Sulforaphane Product Portfolio
- 8.4.5 ETChem Recent Developments
- 8.5 Pioneer Herb Industrial
- 8.5.1 Pioneer Herb Industrial Company Information
- 8.5.2 Pioneer Herb Industrial Business Overview
- 8.5.3 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Pioneer Herb Industrial Glucoraphanin and Sulforaphane Product Portfolio
- 8.5.5 Pioneer Herb Industrial Recent Developments
- 8.6 Shanxi Yian
- 8.6.1 Shanxi Yian Company Information
- 8.6.2 Shanxi Yian Business Overview
- 8.6.3 Shanxi Yian Glucoraphanin and Sulforaphane Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Shanxi Yian Glucoraphanin and Sulforaphane Product Portfolio
- 8.6.5 Shanxi Yian Recent Developments
- 8.7 Anhui Bensentang Biotechnology
- 8.7.1 Anhui Bensentang Biotechnology Company Information
- 8.7.2 Anhui Bensentang Biotechnology Business Overview
- 8.7.3 Anhui Bensentang Biotechnology Glucoraphanin and Sulforaphane Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Anhui Bensentang Biotechnology Glucoraphanin and Sulforaphane Product Portfolio
- 8.7.5 Anhui Bensentang Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Glucoraphanin and Sulforaphane Value Chain Analysis
- 9.1.1 Glucoraphanin and Sulforaphane Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Glucoraphanin and Sulforaphane Sales Mode & Process
- 9.2 Glucoraphanin and Sulforaphane Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Glucoraphanin and Sulforaphane Distributors
- 9.2.3 Glucoraphanin and Sulforaphane Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst